Catherine Sohn

Catherine Angell Sohn was the founder of Sohn Health Strategies LLC, founded in 2010, serving as President.
Current jobs include Non-Executive Chairman at BioEclipse Therapeutics, Inc. since 2016; Director at Jazz Pharmaceuticals, Inc. since 2012; Director at World Affairs Council of Philadelphia; Director at Eversana Life Science Services LLC; Director at Dohmen Co. since 2012; Director at Ariel Pharmaceuticals, Inc.; Independent Director at Altimmune, Inc. since 2023; and Professor at the University of the Sciences in Philadelphia since 2013.
Former jobs include Chairman at Eclipse Therapeutics, Inc.; Independent Director at Lifecore Biomedical, Inc. from 2012 to 2022; Director at Healthcare Businesswomens Association; Independent Director at Seneca Biopharma, Inc. from 2014 to 2017; Director at Consumer Healthcare Products Association; Independent Director at Axcella Health, Inc. from 2019 to 2023; Independent Director at Rubius Therapeutics, Inc. from 2018 to 2023; Director at World Self-Medication Industry Association; Independent Director at Jazz Pharmaceuticals Plc from 2012 to 2024; Independent Director at Maze Therapeutics, Inc. from 2021 to 2026; Director at Armis Biopharma, Inc.; Senior Vice President at GSK Plc from 2003 to 2010; Adjunct Professor at The University of California, San Francisco; Senior Vice President-Business Development at Haleon US LP from 1998 to 2010; Senior Vice President-Worldwide Business at GlaxoSmithKline LLC; VP-Worldwide Strategic Product Development at Smithkline Beecham Pharmaceuticals Ltd. from 1994 to 1998; Trustee at Licensing Executives Society USA & Canada, Inc. from 2008 to 2011; and Professor at Philadelphia College of Pharmacy from 1978 to 1982.
Education includes a doctorate from The University of California, San Francisco, conferred in 1977.